Literature DB >> 24632195

Application of TALEs, CRISPR/Cas and sRNAs as trans-acting regulators in prokaryotes.

Matthew F Copeland1, Mark C Politz1, Brian F Pfleger2.   

Abstract

The last several years have witnessed an explosion in the understanding and use of novel, versatile trans-acting elements. TALEs, CRISPR/Cas, and sRNAs can be easily fashioned to bind any specific sequence of DNA (TALEs, CRISPR/Cas) or RNA (sRNAs) because of the simple rules governing their interactions with nucleic acids. This unique property enables these tools to repress the expression of genes at the transcriptional or post-transcriptional levels, respectively, without prior manipulation of cis-acting and/or chromosomal target DNA sequences. These tools are now being harnessed by synthetic biologists, particularly those in the eukaryotic community, for genome-wide regulation, editing, or epigenetic studies. Here we discuss the exciting opportunities for using TALEs, CRISPR/Cas, and sRNAs as synthetic trans-acting regulators in prokaryotes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632195      PMCID: PMC4162867          DOI: 10.1016/j.copbio.2014.02.010

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  69 in total

Review 1.  Bacterial small RNA-based negative regulation: Hfq and its accomplices.

Authors:  Nicholas De Lay; Daniel J Schu; Susan Gottesman
Journal:  J Biol Chem       Date:  2013-01-29       Impact factor: 5.157

Review 2.  CRISPR-mediated adaptive immune systems in bacteria and archaea.

Authors:  Rotem Sorek; C Martin Lawrence; Blake Wiedenheft
Journal:  Annu Rev Biochem       Date:  2013-03-11       Impact factor: 23.643

3.  Engineering artificial small RNAs for conditional gene silencing in Escherichia coli.

Authors:  Vandana Sharma; Asami Yamamura; Yohei Yokobayashi
Journal:  ACS Synth Biol       Date:  2011-08-29       Impact factor: 5.110

4.  Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

Authors:  Lei S Qi; Matthew H Larson; Luke A Gilbert; Jennifer A Doudna; Jonathan S Weissman; Adam P Arkin; Wendell A Lim
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

5.  A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes.

Authors:  Jonathan L Schmid-Burgk; Tobias Schmidt; Vera Kaiser; Klara Höning; Veit Hornung
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908

6.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

7.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

8.  Artificial repressors for controlling gene expression in bacteria.

Authors:  Mark C Politz; Matthew F Copeland; Brian F Pfleger
Journal:  Chem Commun (Camb)       Date:  2012-12-10       Impact factor: 6.222

9.  Quantitative analysis of TALE-DNA interactions suggests polarity effects.

Authors:  Joshua F Meckler; Mital S Bhakta; Moon-Soo Kim; Robert Ovadia; Chris H Habrian; Artem Zykovich; Abigail Yu; Sarah H Lockwood; Robert Morbitzer; Janett Elsäesser; Thomas Lahaye; David J Segal; Enoch P Baldwin
Journal:  Nucleic Acids Res       Date:  2013-02-13       Impact factor: 16.971

10.  Synergistic and tunable human gene activation by combinations of synthetic transcription factors.

Authors:  Pablo Perez-Pinera; David G Ousterout; Jonathan M Brunger; Alicia M Farin; Katherine A Glass; Farshid Guilak; Gregory E Crawford; Alexander J Hartemink; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-02-03       Impact factor: 28.547

View more
  10 in total

1.  CRISPR-on system for the activation of the endogenous human INS gene.

Authors:  C A Giménez; M Ielpi; A Mutto; L Grosembacher; P Argibay; F Pereyra-Bonnet
Journal:  Gene Ther       Date:  2016-04-04       Impact factor: 5.250

2.  CRISPR interference as a titratable, trans-acting regulatory tool for metabolic engineering in the cyanobacterium Synechococcus sp. strain PCC 7002.

Authors:  Gina C Gordon; Travis C Korosh; Jeffrey C Cameron; Andrew L Markley; Matthew B Begemann; Brian F Pfleger
Journal:  Metab Eng       Date:  2016-07-29       Impact factor: 9.783

Review 3.  CRISPR/Cas9-Based Genome Editing and Its Application in Aspergillus Species.

Authors:  Feng-Jie Jin; Bao-Teng Wang; Zhen-Dong Wang; Long Jin; Pei Han
Journal:  J Fungi (Basel)       Date:  2022-04-30

4.  Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.

Authors:  Mark R Bruder; Michael E Pyne; Murray Moo-Young; Duane A Chung; C Perry Chou
Journal:  Appl Environ Microbiol       Date:  2016-09-30       Impact factor: 4.792

5.  A transcription activator-like effector (TALE) induction system mediated by proteolysis.

Authors:  Matthew F Copeland; Mark C Politz; Charles B Johnson; Andrew L Markley; Brian F Pfleger
Journal:  Nat Chem Biol       Date:  2016-02-08       Impact factor: 15.040

Review 6.  Transcription control engineering and applications in synthetic biology.

Authors:  Michael D Engstrom; Brian F Pfleger
Journal:  Synth Syst Biotechnol       Date:  2017-10-04

Review 7.  Protein Engineering Strategies to Expand CRISPR-Cas9 Applications.

Authors:  Lucas F Ribeiro; Liliane F C Ribeiro; Matheus Q Barreto; Richard J Ward
Journal:  Int J Genomics       Date:  2018-08-02       Impact factor: 2.326

Review 8.  Converting a Periplasmic Binding Protein into a Synthetic Biosensing Switch through Domain Insertion.

Authors:  Lucas F Ribeiro; Vanesa Amarelle; Liliane F C Ribeiro; María-Eugenia Guazzaroni
Journal:  Biomed Res Int       Date:  2019-01-03       Impact factor: 3.411

9.  Efficient genome editing in filamentous fungi via an improved CRISPR-Cas9 ribonucleoprotein method facilitated by chemical reagents.

Authors:  Gen Zou; Meili Xiao; Shunxing Chai; Zhihua Zhu; Ying Wang; Zhihua Zhou
Journal:  Microb Biotechnol       Date:  2020-08-25       Impact factor: 5.813

10.  Programmable control of bacterial gene expression with the combined CRISPR and antisense RNA system.

Authors:  Young Je Lee; Allison Hoynes-O'Connor; Matthew C Leong; Tae Seok Moon
Journal:  Nucleic Acids Res       Date:  2016-02-02       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.